Systemically administered anti-TNF therapy ameliorates functional outcomes after focal cerebral ischemia
2014 · Journal of Neuroinflammation · 99 citations
https://doi.org/10.1186/s12974-014-0203-6
M
Matilda Degn
Gubra (Denmark)(DK)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
47
Papers
1.4K
Citations
22
h-index
30
i10-index
Matilda Degn is an academic researcher from Gubra (Denmark). The author has contributed to research in topics: Neuroinflammation and Neurodegeneration Mechanisms & Multiple Sclerosis Research Studies & Acute Lymphoblastic Leukemia research. The author has an h-index of 22, co-authored 40 publications.
ORCID: 0000-0003-3093-3525Papers by this author
worksCerebrospinal fluid chitinase‐3‐like 2 and chitotriosidase are potential prognostic biomarkers in early multiple sclerosis
2016 · European Journal of Neurology · 63 citations
https://doi.org/10.1111/ene.12960
Conditional ablation of myeloid TNF increases lesion volume after experimental stroke in mice, possibly via altered ERK1/2 signaling
2016 · Scientific Reports · 41 citations
https://doi.org/10.1038/srep29291
Early-stage inflammation changes in supraspinatus muscle after rotator cuff tear
2022 · Journal of Shoulder and Elbow Surgery · 31 citations
https://doi.org/10.1016/j.jse.2021.12.046
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat